IP Library Granted Patent US 8,461,113
Granted Patent B2
US 8,461,113 · App. 12/483,494 · Granted Jun 11, 2013

Elastin digest compositions and methods utilizing same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,461,113
App. No.
12/483,494
Granted
Jun 11, 2013
Kind
B2
Abstract

The present invention provides compositions for the therapeutic and/or cosmetic treatment of Elastin comprising tissues. Therapeutic and cosmetic compositions comprising an elastin digest stimulate the endogenous production of Elastin and appear to enhance the elasticity of the skin and provide an external supply of peptide precursors of Elastin that penetrate into the tissue to which it is applied. The present invention describes compositions containing an elastin digest derived from proteolytic digestion of insoluble elastin derived from mammalian ligaments with a protein digesting composition, such as proteinase K. The elastin digest is a mixture of elastin peptides wherein the elastin peptide mixture comprises peptides of the sequence GXXPG, wherein X represents one of the natural amino acids. The elastin digest of the present invention may also comprise epitopes of cytokines, growth factors and di-peptides. Methods of using these elastin digest comprising compositions for treating tissues in need of increased elasticity and or Elastin are described.

Claims (20)

1. A method of stimulating production of fibrillin, the method comprising administering to a site in need thereof on a mammal an effective amount of a composition comprising an elastin peptide having an amino acid selected from the group consisting of PGGVLPG (SEO ID No. 47),VGVVPG (SEQ ID No. 48), IGLGPGGV (SEQ ID. No. 49) and a combination thereof, wherein fibrillin production is stimulated.

2. The method of claim 1 , wherein the composition is derived from proteolytic digestion of elastin derived from a mammal.

3. The method of claim 2 , wherein the elastin derived from a mammal is insoluble elastin.

4. The method of claim 2 , wherein the elastin derived from a mammal is solubilized chemically or enzymatically prior to digestion.

5. The method of claim 2 , wherein the proteolytic digestion is by a protease selected from the group consisting of human elastase enzyme and proteinase K enzyme.

6. The method of claim 2 , wherein the composition comprises an additional elastin peptide.

7. The method of claim 6 , wherein the additional elastin peptide has an amino acid sequence consisting of GXXPG, wherein X represents one of the natural amino acids.

8. The method of claim 1 , further including heating the site.

9. The method of claim 1 , wherein administration establishes an effective concentration of the composition at the site.

10. The method of claim 1 , wherein administration is by injection or topical administration.

11. The method of claim 1 , wherein the site is comprised of cutaneous tissue.

12. The method of claim 11 , wherein the cutaneous connective tissue comprises mouth tissue.

13. The method of claim 11 , wherein the cutaneous connective tissue comprises follicles.

14. The method of claim 11 , wherein the cutaneous connective tissue comprises corneal tissue.

15. The method of claim 1 , wherein the elastin digest comprises a mixture of elastin peptides.

16. The method of claim 1 , wherein the elastin digest comprises epitopes, cytokines, growth factors and di-peptides.

17. The method of claim 1 , wherein the composition is in a form chosen from a group consisting of an emulsion, a lotion, a spray, an aerosol, a powder, an ointment, a cream, a foam and a gel.

18. The method of claim 1 wherein the composition further comprises an additive selected from a group consisting of tropoelastin excretion inducers, tropoelastin synthesis stimulators, compounds inducing deposition on microfibril scaffolds, compounds which induce lysyl oxidase synthesis, copper ion sources, and combinations thereof.

19. The method of claim 1 , wherein the composition further comprises a chemical preservative.

20. The method of claim 19 , wherein the chemical preservative is cetylpyridinium chloride.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2024
From: ELASTOGENESIS LLC
To: NULASTIN, INC.
Reel/Frame 068190/0171 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2019
From: HUMAN MATRIX SCIENCES, LLC
To: ELASTOGENESIS, LLC
Reel/Frame 048891/0950 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2009
From: MITTS, THOMAS; JIMENEZ, FELIPE
To: HUMAN MATRIX SCIENCES, LLC
Reel/Frame 023013/0262 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2009
From: MITTS, THOMAS; JIMENEZ, FELIPE
To: HUMAN MATRIX SCIENCES, LLC
Reel/Frame 022818/0825 →